Advertisement
To access the live and subsequently archived webcast of the presentation,visit the Investor Relations section of Genomic Health's website athttp://investor.genomichealth.com. Please connect to the website at least 15minutes prior to the beginning of the presentation to allow for any necessarysoftware downloads. An archived replay will be available for three monthsbeginning 24 hours after the live presentation.
Advertisement
About Genomic Health
Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused onthe development and commercialization of genomic-based clinical laboratoryservices for cancer that allow physicians and patients to make individualizedtreatment decisions. In 2004, Genomic Health launched its first test,Oncotype DX(R), which has been shown to predict the likelihood of breastcancer recurrence and the likelihood of chemotherapy benefit in a largeportion of early-stage breast cancer patients. The company was founded in2000 and is located in Redwood City, California. For more information, pleasevisit http://www.genomichealth.com.
SOURCE Genomic Health, Inc.
